Orthocell (ASX:OCC) ROE % Adjusted to Book Value : -7.21% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Orthocell ROE % Adjusted to Book Value?

Orthocell's ROE % for the quarter that ended in Jun. 2024 was -116.29%. Orthocell's PB Ratio for the quarter that ended in Jun. 2024 was 16.14. Orthocell's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -7.21%.

Orthocell ROE % Adjusted to Book Value Historical Data

The historical data trend for Orthocell's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthocell ROE % Adjusted to Book Value Chart

Orthocell Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-13.75

-7.22

-8.40

-6.89

-8.33

Orthocell Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-9.13	-7.61	-6.29	-6.74	-7.21

Competitive Comparison of Orthocell's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Orthocell's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orthocell's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orthocell's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Orthocell's ROE % Adjusted to Book Value falls into.

Orthocell ROE % Adjusted to Book Value Calculation

Orthocell's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-134.45%	/	16.14
	=	-8.33%

Orthocell's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-116.29%	/	16.14
	=	-7.21%

Orthocell ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Orthocell's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Orthocell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150

Website

https://www.orthocell.com.au

Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.